Let the Drug Pricing Games Begin!
nder pressure from the White House, Big Pharma has been touting “discounts” via Direct to Consumer (DTC) websites. Meanwhile, the Trump administration promises to unveil its own prescription website, immodestly named TrumpRx, in 2026. Prescription drug prices obviously are still too high, though President Biden’s Inflation Reduction Act (IRA) of 2022 was beginning to make headway in bringing them down. Unlike Biden’s IRA, these latest gestures by Big Pharma and the Trump Administration should be viewed with a healthy dose of skepticism.
Trump Shutdown Could Snag Social Security, Medicare
In normal times, a government shutdown --- while unfortunate --- would not be cause for immediate alarm for people on Social Security and Medicare. But these are not normal times. The Trump administration has made the shutdown more perilous for the most vulnerable Americans because of its campaign to undermine the delivery of both programs --- not to mention the President’s recent threat to cut benefits.
Social Security Comish Would Consider Raising Retirement Age
Despite Trump’s pledge not to cut Social Security, administration officials keep letting the real agenda slip out. First, Treasury Secretary Scott Bessent hinted that privatizing Social Security was on the table. Now, Social Security Commissioner Frank Bisignano says he’s open to the idea of raising the retirement age. (The current full retirement age is 67; congressional Republicans have floated proposals to raise it as high as 70.) In an interview on Fox Business News last week, host Maria Bartiromo asked Bisignano if he’d “consider raising the retirement age,” to which the commissioner replied, “I think everything’s being considered.”
Upcoming Celebration Event
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin a laoreet magna, nec interdum nibh. Aliquam at lacinia arcu. Fusce vulputate mauris quis eros efficitur vehicula. Sed eget volutpat ipsum. Duis eget dui facilisis, interdum sapien a, rhoncus dolor. Sed pulvinar risus vel metus blandit, non consequat risus rhoncus.








